IHH Annual Report 2023

Financial Statements Attributable to owners of the Company Non-distributable Share capital Share option reserve Revaluation reserve Hedge reserve Group Note RM’000 RM’000 RM’000 RM’000 At 1 January 2022 19,614,918 33,874 83,434 16,587 Foreign currency translation differences from foreign operations – – – – Hyperinflationary adjustments – – – – Hedge of net investments in foreign operations – – – – Cash flow hedge – – – 7,869 Costs of hedging – – – – Remeasurement of defined benefit liabilities – – – – Total other comprehensive income for the year 29 – – – 7,869 Profit for the year – – – – Total comprehensive income for the year – – – 7,869 Contributions by and distributions to owners Share-based payment transactions – 3,319 – – Transfer to share capital on share options exercised 69,963 (14,221) – – Cancellation of vested share options – (189) – – Dividends to owners of the Company 33 – – – – Dividends to non-controlling interests – – – – Redemption and payment of coupon on perpetual securities – – – – Accrued perpetual securities distribution 19 – – – – Remeasurement of liabilities on put options granted to non-controlling interests – – – – Transfer per statutory requirements – – – – Others – – – (16,180) 69,963 (11,091) – (16,180) Changes in ownership interests in subsidiaries – – – (2) Total transactions with owners 69,963 (11,091) – (16,182) At 31 December 2022 19,684,881 22,783 83,434 8,274 Statements of Changes in Equity for the year ended 31 December 2023 The notes on pages 148 to 248 are an integral part of these financial statements. IHH Healthcare Berhad 140

RkJQdWJsaXNoZXIy NDgzMzc=